18 Jun The Cap Times: Exact Sciences in Madison unveils trio of cancer detection tests
Exact Sciences operates a research and development lab at University Research Park in Madison.
KAYLA WOLF / WISCONSIN STATE JOURNAL
Exact Sciences, the Madison-based biotech company, is expanding its cancer detection portfolio this year with two recently launched tests and another set for the coming months.
Cologuard Plus, an updated version of the company’s flagship colorectal cancer screening test, came out in March. Oncodetect, a blood test for detecting molecular residual disease, followed in May.
In the second half of the year, the company plans to launch Cancerguard EX, a test to screen for multiple cancers that begin in an organ, such as lung cancer, stomach cancer or ovarian cancer.
In an interview with the Cap Times, CEO Kevin Conroy said the new tests align with Exact Sciences’ core mission, centering the patient experience and creating positive health outcomes.
“Our purpose is to help eradicate cancer with tests that prevent it, detect it earlier and guide treatment,” Conroy said. “Everything we do is focused on trying to make that a reality, and each of these tests plays a role in each of those things.”